Skip to main content
Premium Trial:

Request an Annual Quote

Albert Einstein College to Use $25M Donation for Epigenomics, Translational Research

NEW YORK (GenomeWeb News) – The Albert Einstein College of Medicine of Yeshiva University will use funds from a $25 million private gift to establish an epigenomics research facility and to fund genetics and translational medical research.
 
The college said Tuesday it plans to use $7 million of the donation from Ruth and David Gottesman to start the Center for Epigenomics. Some of the money will support the Michael F. Price Center for Genetic and Translational Medicine, and $15 million will be used to start the David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.
 
Ruth Gottesman, a former faculty member at the college, was elected chair of Einstein's board of overseers in 2007.
 
The epigenomics center will be headed by Einstein researcher John Greally, who has developed a method for detecting the methylation patterns that characterize breast tumors and other cancers.
 
The college also said that it will use $3 million to start a Clinical Skills Facility.
 
"In discussions with the college, we determined that stem cells, epigenomics and clinical training were areas where we could help make an important contribution, both to Einstein and to the future of biomedical research," Ruth Gottesman said in a statement.
 
The Price Center for Genetic and Translational Medicine is scheduled to open in June 2008.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.